Peter Smith, DVM, DACLAM
DownloadHi-Res Photo
Cards
Appointments
Comparative Medicine
Primary
Titles
Director, Residency Training Program
Contact Info
Yale School of Medicine
PO Box 208016
New Haven, CT 06520-8016
United States
Appointments
Comparative Medicine
Primary
Titles
Director, Residency Training Program
Contact Info
Yale School of Medicine
PO Box 208016
New Haven, CT 06520-8016
United States
Appointments
Comparative Medicine
Primary
Titles
Director, Residency Training Program
Contact Info
Yale School of Medicine
PO Box 208016
New Haven, CT 06520-8016
United States
About
Titles
Professor of Comparative Medicine
Director, Residency Training ProgramAppointments
Comparative Medicine
ProfessorPrimary
Other Departments & Organizations
Education & Training
- DVM
- Michigan State University (1996)
- Postdoctoral Fellow
- University of Michigan
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Peter Smith's published research.
Publications Timeline
A big-picture view of Peter Smith's research output by year.
Steven Wilson, DVM, DACLAM
6Publications
3Citations
Publications
2012
Chapter 46 Deer Mice, White-Footed Mice, and their Relatives
Smith P, Scholz J, Wilson S. Chapter 46 Deer Mice, White-Footed Mice, and their Relatives. 2012, 1075-1088. DOI: 10.1016/b978-0-12-380920-9.00046-8.Peer-Reviewed Original ResearchCitations
2007
Reliability of soiled bedding transfer for detection of mouse parvovirus and mouse hepatitis virus.
Smith PC, Nucifora M, Reuter JD, Compton SR. Reliability of soiled bedding transfer for detection of mouse parvovirus and mouse hepatitis virus. Comparative Medicine 2007, 57: 90-6. PMID: 17348296.Peer-Reviewed Original Research
2003
Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.
Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. Journal Of The National Cancer Institute 2003, 95: 878-89. PMID: 12813171, DOI: 10.1093/jnci/95.12.878.Peer-Reviewed Original Research
2002
Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice.
Zhang J, Dai J, Lin DL, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET. Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice. Journal Of Bone And Mineral Research : The Official Journal Of The American Society For Bone And Mineral Research 2002, 17: 1256-63. PMID: 12096839, DOI: 10.1359/jbmr.2002.17.7.1256.Peer-Reviewed Original Research
2001
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.
Zhang J, Dai J, Qi Y, Lin DL, Smith P, Strayhorn C, Mizokami A, Fu Z, Westman J, Keller ET. Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. The Journal Of Clinical Investigation 2001, 107: 1235-44. PMID: 11375413, PMCID: PMC209296, DOI: 10.1172/JCI11685.Peer-Reviewed Original ResearchProstate carcinoma skeletal metastases: cross-talk between tumor and bone.
Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS. Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Reviews 2001, 20: 333-49. PMID: 12085970.Peer-Reviewed Original Research
Get In Touch
Contacts
Email
Mailing Address
Yale School of Medicine
PO Box 208016
New Haven, CT 06520-8016
United States